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Abstract The response of confluent monolayers of normal and 
cystic fibrosis (CF) pancreatic epithelial cells to stimulation by 
extracellular ATP and ATP analogues was investigated in terms 
of mucin secretion. Mucin secretion was measured as release of 
M1 antigens by a direct sandwich enzyme immunoassay. 
Extracellular ATP provoked rapid (<15 min) and strong mucin 
secretion (+480 + 35%) by the normal pancreatic cell lines but 
was not able to induce mucin secretion by the CF cell lines. The 
order of efficacy of nucleotide agonists with ATP >AI )P  
> AMP > adenosine was that of typical P2-purinergic receptors. 
ATP induced a rapid and transient intraceilular [Ca2+l 
mobilization in both normal and CF pancreatic epithelial cells. 
This work demonstrated that CFTR seemed to mediate ATP- 
dependent mucin secretion. 
Key  words: Nucleotides; CAPAN;  CFPAC;  Ml  antigens; 
CFTR 
I. Introduction 
Cystic fibrosis is a genetic disease characterized by mucus 
hypersecretion, persistent bacterial infection and inflammation 
of the airways. The defect lies in mutations of the membrane 
protein called CFTR [1], possessing a cAMP-dependent chlor- 
ide channel activity [2], located in the apical membrane of 
many secretory epithelial cells [3]. 
Extracellular triphosphate nucleotides are increasingly re- 
cognized as potentially important regulators of epithelial ion 
transport [4]. Exogenous ATP and UTP can bind to a P2- 
purinoceptor located in the apical cell membrane of airway 
epithelia [4], therefore inducing mobilization of intracellular 
calcium through phospholipase C, which consequently acti- 
vates a Ca2+-dependent C1- conductance. ATP, reported to 
be a potent secretagogue of electrolyte, has been consequently 
proposed for use as a therapeutic agent for cystic fibrosis in 
order to bypass the defective function of CFTR,  and to re- 
store chloride secretion in CF patients [5]. Recent reports 
demonstrate that extracellular ATP is also a very potent se- 
cretagogue of mucin secretion in goblet cells from the respira- 
tory tract [6], via a P2-receptor-mediated mechanism [7,8], and 
of SLPI (secretory leucoprotease inhibitor) in human tracheal 
gland cells [9]. 
Several gastrointestinal cell lines have been found to be 
mucin secreting and used to study the regulation of mucin 
secretion [10,11]. Particularly mucin and electrolyte secretion 
in response to ATP has been observed in the human intestinal 
goblet cell line HT29-Cl.16E [10]. No work has been reported 
about ATP-dependent mucin secretion in normal and cystic 
fibrosis pancreatic epithelial cells in culture: it therefore 
seemed interesting to us to study the differential ATP-depend- 
ent mucin secretion and the role of Ca 2+ as a second mes- 
senger. 
In a previous study, we found secretion of mucin M1 anti- 
gens by a pancreatic cell line derived from a patient with 
cystic fibrosis: the CFPAC-1 cell line [12]. Mucin M1 antigens 
were initially found in gastric mucosae and in human ovarian 
mucinous cystic fluids [13]. These antigens are borne by high- 
molecular-weight components, which exhibit blood-group-re- 
lated antigens and a density of 1.4 by CsCI density-gradient 
ultracentrifugation; they are consequently associated with 
mucins [14]. M1 antigens were subsequently shown to be 
also present and secreted by a mucin producing cell line: 
CAPAN-1 [12,15,16], by the CFPAC-1 cells that were stably 
transfected with a retroviral vector containing the full-length 
cDNA encoding wild-type CFTR (CFPAC-PLC-CFTR6) and 
by the CFPAC cells that were mock-transfected with vector 
alone (CFPAC-PLJ6) (unpublished ata). We therefore took 
into account the property of the CFPAC cell lines to produce 
mucin M1 antigens to compare the ATP-induced mucin secre- 
tion in CF and reverted CF cells. CAPAN-1 cells were used as 
control cells. 
Our results have shown that ATP is not able to induce 
mucin secretion by the CF and mock-transfected cell lines 
whereas it provokes rapid and strong mucin secretion by the 
reverted cell lines and the control cells. However, ATP may be 
bound in all the different cells to a P2-purinoceptor as shown 
by the induction of a rapid and transient intracellular calcium 
mobilization. These observations provide for the first time the 
evidence of an alteration in the secretory control mechanism 
of CF pancreatic ell mucins and that this alteration is distinct 
from the second messenger system. 
2. Materials and methods 
2.1. Chemicals and solutions 
Adenosine, adenosine-5'-monophosphate (AMP), adenosine-5'-di- 
phosphate (ADP), adenosine-5'-triphosphate (ATP), adenosine-5'- 
thiotriphosphate (ATPyS), uridine-5'-triphosphate (UTP), dimethyl 
sulfoxide (DMSO), forskolin, carbachol, vasoactive intestinal peptide 
(VIP) and RPMI-1640 medium were obtained from Sigma (St. Louis, 
MO, USA). Stock solutions of each secretagogue or agent were pre- 
pared as follows: adenosine, AMP, ADP, ATP, ATPyS, UTP were 
dissolved in the RPMI-1640 medium at 10 -2 M. Forskolin was dis- 
solved in ethanol at 10 2 M to a final concentration of 10 5 M. 
Carbachol was diluted in the culture medium and used at 10 -3 M. 
VIP was dissolved in phosphate buffer pH 7.2 at 10 -3 M to a final 
concentration of 10 -6 M, in the culture medium. 
*Corresponding author. Fax: +33 91 78 68 95. 
2.2. Cell lines 
The CAPAN-1 cell line used in this study was established by F6gh 
et al. [17] from a liver metastasis resulting from a pancreatic adeno- 
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carcinoma in a 40-year-old patient. CFPAC-1 is a pancreatic adeno- 
carcinoma cell line derived from a homozygous patient for phenyl- 
alanine deletion at position 508 (AF 508) and expresses the appropri- 
ate CF gene product [18]. CFPAC-I cells were stably transfected with 
a retroviral vector (PLJ) that contained the full-length cDNA encod- 
ing wild type CFTR: CFPAC-PLJ-CFTR6 [19]. CFPAC-PLJ6 were 
CFPAC-1 cells exposed to control retrovirus alone (PLJ) [19]. Those 
three CFPAC cell lines were generous gifts from Professor R.A. Friz- 
zell (University of Alabama in Birmingham, USA). The presence of 
normal and mutated CFTR mRNA in CFPAC-PLJ-CFTR6 cells was 
assessed in our laboratory using cDNA-PCR amplification and poly- 
acrylamide gel electrophoresis (data not shown). 
2.3. Cell culture 
All cell lines were routinely grown in RPMI-1640 medium supple- 
mented with 15% FCS for the CAPAN-1 cell line as described by 
Levrat et al. [20]; with 10% FCS for the CFPAC cell lines. Media 
were supplemented with penicillin (100 units/ml), streptomycin (100 
~g/ml) and fungizone (0.25 mg/ml). Cells were maintained at 37°C in a 
5% COJ95% air atmosphere. They were regularly harvested with a 
0.05% trypsin solution, in 0.53 mmol/l EDTA after 9 and 14 days of 
culture. Cells were seeded onto Falcon 6-well cell culture plates, each 
well containing about 5 × 105 cells in 2 ml of culture medium, for the 
different stimulations. Culture supernatants of confluent cultures were 
used for secretion studies between days 8 and 14. 
2.4. M1 antigens measurement 
Confluent cultures of the different cells grown on 6-well plates were 
rinsed two times for 2 h with serum-free culture medium and then 
exposed either for 5, 15 and 30 min to 0.1 mM and 1 mM ATP or for 
30 min to ATP (from 10 6 M to 10 -3 M) to study cumulative dose- 
response curve or for 30 min to fixed concentrations (10 -3 M) of 
different nucleotides or agents. The culture medium was harvested 
and M1 antigens were measured by a direct sandwich enzyme immu- 
noassay, using two monoclonal antibodies (MAbs): 1-13 M1 and 9- 
13 MI [12]. These antibodies were shown to recognize the a and d 
epitopes present on the same peptide core of high-molecular-weight 
macromolecules characterized asM 1 antigens [14]. The detection limit 
of the assay optimized with streptavidin-peroxidase was 1.6 ng/ml. 
This ELISA was highly specific, sensitive, reproducible, raised to 
520 ng of protein/ml and quickly performed. The M1 antigen secre- 
tory rate (M1 Ag S.R.) was defined as the ratio of MI Ag secreted by 
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Fig. 1. Time dependence of extracellular ATP-stimulated secretion 
of mucin in confluent CAPAN-1 cells (11), CFPAC-1 cells (O), 
CFPAC-PLJ-CFTR6 cells (A) and CFPAC-PLJ6 cells (©). Mucin 
secretion after addition of 1 mM ATP to culture medium. The M1 
Ag secretory rate (M1 Ag S.R.: ratio of MI Ag secreted by the as- 
say to MI Ag secreted by control) was calculated and compared to 
control which has a value of 1. Each point represents mean + S.D. 
for triplicates from two different experiments (n= 6). Statistical sig- 
nificances between the response to agents and the control in this 
and the following figures are indicated by *:P<0.05, **:P<0.01 
and *** :P < 0.001. 
cells upon stimulation with different agents to M 1 Ag secreted by the 
same unstimulated cells which has a value of 1. In each experiment, 
the mean M1 Ag secretory rate was determined from at least 6 assays. 
2.5. Single cell [Ca 2+ ] measurement 
Cells were seeded at 104 cells/cm ~ onto glass coverslips and cultured 
for 48 h in complete culture medium. After four 1 h washes in serum- 
free medium, cells were incubated for 30 min in the dark at 37°C in a 
10 mM Tris/HC1 buffer containing 135 mM NaCI, 5 mM KCI, 1 mM 
CaC12 and 1 ~tM Fluo 3/AM (from a 0.1 mM, 3% Pluronic F127 stock 
solution prepared in 20% DMSO). Changes in fluorescence were mon- 
itored at 37°C using the same incubation buffer and a fluorescence 
microscopy imaging system consisting of an Olympus IMT2 inverted 
phase-contrast microscope with a × 40 objective l ns and equipped for 
epifluorescence and photometry with a Lhesa 4015 SIT video camera 
as described in detail previously [9]. When the baseline level of fluor- 
escence had stabilized, 0.1 mM of ATP was added to the cell prepara- 
tion. This experiment was performed three times and 3-6 single cells 
of each cell line were analyzed per experiment. Results within an 
experiment and between the experiments were found to be highly 
reproducible. 
2.6. Statistics 
Each experiment was repeated at least six times. All results are 
expressed as means+standard deviation (SD). Differences between 
means were analyzed by paired or unpaired t-tests as appropriate: 
thus, a paired or unpaired Student's t-test was used to show statistical 
significance. A P value of < 0.05 was considered significant. Statistics 
were carried out using the Software Statwork 1.2. 
3. Results 
3.1. Constitutive secretion o f  M1 antigens by the pancreatic ell 
lines 
Repeated measurements of M1 antigens by the superna- 
tants of the different cells at confluence during unstimulated 
basal periods were similar and remarkably reproducible, 
showing a continuous and constant release of 0.8 +0.16 ng/ 
l0 n cells for CFPAC-1;  1.28+0.08 ng/105 cells for CFPAC-  
PLJ -CFTR6; 1.04 +0.064 ng/105 cells for CFPAC-PLJ6 cells 
and 1.12 + 0.08 ng/105 cells for CAPAN-1. These results were 
the average of 10 different assays at 1, 12 and 24 h respec- 
tively. 
3.2. ATP  as secretagogue for  mucin release 
As shown in Fig. 1, the addition of ATP to the CAPAN-1 
and to the CFPAC-PL J -CFTR6 cell lines elicited a rapid and 
strong stimulation of mucus release quantified by M1 antigen 
measurement. By contrast, the addition of ATP to the 
CFPAC-1 and to the CFPAC-PLJ6 cell lines did not induce 
any increase of M1 antigens. At 1 mM ATP, an effect was 
seen as early as 5 min and for the CAPAN-1 and the CFPAC-  
PLJ -CFTR6 cell lines the release was maximal between 15 and 
30 min. Similar results were obtained at 0.1 mM ATP (data 
not shown). The last time (30 min) was used in further experi- 
ments to characterize this process. The dose-response curve 
for the action of ATP on M1 antigens ecretion is shown in 
Fig. 2. No ATP response of the CFPAC-1 and of CFPAC-  
PLJ6 cells was observed at any concentration. A strong re- 
sponse was observed with the CFPAC-PL J -CFTR6 cell line 
and the CAPAN-1 cell line: the increase of secretion was 
respectively +483 _+ 35% (p < 0.001) and +450 _+ 51% 
(P<0.001).  These results argue in favor of the presence of 
an ATP receptor on the CFPAC-PL J -CFTR6 and on the 
CAPAN-1 cell lines. In order to determine which type of 
ATP receptor is expressed, the effects of other nucleotides, 
ATP analogues and adenosine were examined on the four 
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Fig. 2. Dose-response curve of extracellular ATP-stimulated secre- 
tion of mucin, by CAPAN-1 cells (first columns), CFPAC-I cells 
(second columns), CFPAC-PLJ-CFTR6 cells (third columns) and 
CFPAC-PLJ6 cells (fourth colums). Dose response tbr ATP action 
was measured after 30 min of exposure. The M1 Ag S.R. and statis- 
tical significance as for Fig. I. 
cell lines. All drugs were used at the concentration of 1 mM. 
The sequence of efficacy of the different analogues tested was: 
ATP > ADP > AMP > adenosine > UTG (Fig. 3). Only CA- 
PAN-1 and the CFPAC-PL J -CFTR6 cell lines were stimu- 
lated. No response was obtained with the original and 
mock-transfected CFPAC-1 cell lines. Compared with the 
stimulation by ATP, the results from exposing the luminal sur- 
face to other selected nucleotides were modest: with CAPAN-  
1 and CFPAC-PL J -CFTR6 they were respectively: +69 _+ 24% 
(P < 0.05) and +98 + 8% (P < 0.05) for ADP;  +55 + 35% (n.s.) 
and +72_+17% (P<0.05)  for AMP;  +22+27% (n.s.) and 
+47_+17% (n.s.) for adenosine; and +10_+12% (n.s.) and 
+17_+24% (n.s.) for UTP. ATPTS, the poorly hydrolyzable 
analogue of ATP, used at 0.1 mM concentration gave results 
close to those obtained with ATP, in terms of mucin secretion, 
indicating that ATP itself, and not a contaminant of hydro- 
lysis product, was the real agonist. 
cell line. The addition of 0.1 mM ATP induced a rapid [Ca2+]i 
increase which then declined. The transient [Ca2+]i mobiliza- 
tion by ATP of the three cell lines was similar in amplitude 
and duration which was between 100 and 160 s. The maximal 
fluorescence ratios were 2.4_+0.2 (n--13), 2.6_+0.15 (n--16), 
and 2.5_+0.4 (n=9), for CFPAC-PLJ6,  CFPAC-1 and 
CFPAC-PL J -CFTR6 cells, respectively. No difference was ob- 
served when the cells were investigated in the presence of 
extracellular [Ca 2+] (1.8 mM) or in a Ca2+-free (< 50 nM) 
medium indicating that this observed [Ca2+]i mobilization de- 
rived from internal stores. 
3.4. Cholinergic agonist, forskolin, VIP and mucin secretion 
To evaluate the potential importance of ATP-mediated mu- 
cin secretion, the efficacy of the different signalling systems 
was compared. We carried out a series of experiments com- 
paring the mucin MI secretion induced by carbachol, a chol- 
inergic agonist, forskolin, an activator of adenylate cyclase, 
the natural secretagogue VIP and ATP (Fig. 5). The strongest 
responses were obtained with the CAPAN-1 and the CFPAC-  
PL J -CFTR6 cell lines with all the above mentioned secreta- 
gogues. The increase of secretion was, with the CAPAN-1 and 
the CFPAC-PL J -CFTR6 cell lines respectively: for carbachol: 
+55 + 5% (n.s.) and +88 + 35% (P < 0.02); for VIP: +70_+ 40% 
(n.s.) and +166+50% (P<0.01) ;  for forskolin: +90_+35% 
(P < 0.01) and + 170 _+ 46% (P < 0.01). The compared increase 
of secretion for ATP with the CAPAN-1 and the CFPAC- 
PLJ -CFTR6 cell lines was respectively: +250+25% 
(P<0.001)  and +375_+24% (P<0.001).  No significant re- 
sponse was observed with the CFPAC- I  and with the 
CFPAC-PLJ6 cell lines. The increase of secretion stimulated 
by ATP was about double the amplification of that of the 
other secretagogues, used however at their maximal effective 
dose determined in preliminary experiments. Carbachol, for- 
skolin and VIP have some efficacy in the mucin release by the 
CFPAC-PL J -CFTR6 and the CAPAN-1 cell lines, but little or 
no effect on the CFPAC-1 and the CFPAC PLJ 6 cell lines. 
3.3. Intracellular [Ca 2+ ] mobilization 
Since ATP stimulated mucin release by CFPAC-PLJ -  
CFTR6 cells but not by CFPAC-1 cells nor by CFPAC-  
PLJ6 cells, we checked the presence of a functional P2 recep- 
tor on these cells by analyzing [Ca2+]i mobilization by ATP. 
Fig. 4 shows representative experiments of a single cell of each 
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Fig. 3. Potency of ATP analogues on mucin secretion of CAPAN-1 
cells (first columns), CFPAC-I cells (second columns), CFPAC-PLJ- 
CFTR6 cells (third columns) and CFPAC-PLJ6 cells (fourth col- 
umns). Cells were exposed for 30 min to 10 ~ M of each agonist. 
The M1 Ag S.R. and statistical significance as for Fig. 1. 
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Fig. 4. Actions of 0.1 mM of ATP on intracellular Ca 2+ concentra- 
tion ([Ca2+]i) in CFPAC-1 cells (e), CFPAC-PLJ-6 cells (O), and 
CFPAC-PLJ-CFTR-6 cells (A). lntracellular Ca 2+ mobilization was 
detected in single cells loaded with Fluo 3/AM. Arrow, ATP addi- 
tion to the cells. Data are from representative experiments. 
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Fig. 5. Comparison of the efficacy of ATP, carbachol, forskolin and 
VIP on mucin secretion in CAPAN-I cells (first columns), CFPAC- 
1 cells (second columns), CFPAC-PLJ-CFTR6 cells (third columns) 
and CFPAC-PLJ6 cells (fourth columns). Cells were exposed for 30 
min to 10 -3 M ATP, 10 3 M carbachol, 10 5 M forskolin or 10 -G 
M VIP. The MI Ag S.R. and statistical significance as for Fig. 1. 
4. Discussion 
The aim of the present study was to determine the effect of 
ATP and its analogues on mucin secretion and [Ca2+]i mobi- 
lization in CF and CF reverted pancreatic epithelial cells in 
culture. It is well known that via a purinergic receptor in the 
apical cell membrane, ATP may stimulate CI- secretion in 
both CF and normal epithelia when applied in micromolar 
concentrations [4,21]. However, the ATP-induced mucin re- 
lease in both CF and CF reverted epithelial cells has not yet 
been studied. Since ATP is proposed to be a therapeutic agent 
in CF, the most deleterious yndrome being mucus hyperse- 
cretion, it seemed to us very important o examine ATP-in- 
duced mucin secretion in both CF and CF reverted pancreatic 
epithelial cells in culture. Our findings showed a rapid and 
strong effect of ATP on mucin secretion by control epithelial 
cells and the reverted CF cells but no effect on the CFPAC-1 
cells (original and mock-transfected). It has already been 
shown that the retrovirus-mediated transfection of cDNA 
for wild type CFTR into CFPAC-1 cells conferred cAMP- 
dependent regulation of C1 conductance [19], alleviated the 
alteration of sulfate transport via an anion exchange mechan- 
ism [22] and corrected the defect in intracellular t afficking of 
the CF antigen [23]. 
Our present data show that transfection of these pancreatic 
CF cells with normal cDNA was also able to restore the 
defective ATP-induced mucin secretion observed in the CF 
cells. Our results are in keeping with the data from Lloyd 
Mills et al. [24] which directly show that the incorporation 
of anti-CFTR antibodies into submandibular cells inhibited 
]3-adrenergic-stimulated mucin secretion. In addition, observa- 
tions were recently reported showing that adenovirus- 
mediated gene transfer of CFTR to immortalized CF human 
tracheal epithelial cells restored defective cAMP-dependent 
secretion not only of chloride but also of glycoconjugates 
[25]. The presence of a functional CFTR protein seems there- 
fore to be necessary for the regulation of glycoconjugate s - 
cretion, however the mechanism of CFTR contribution to this 
process still remains unclear. 
For a better insight into the receptors mediating the secre- 
tory responses of normal pancreatic epithelial cells and of 
pancreatic epithelial CF cells to extracellular ATP, we deter- 
mined the relative efficacy of several agonists in stimulating 
mucin secretion. The observed rank order of efficiency of sev- 
eral nucleotides tested at 1 mM concentration on mucin secre- 
tion with ATP > ADP > AMP > adenosine was that of typical 
P2-purinergic receptors (Fig. 3). The possibility that some of 
the effects of extracellular ATP could be accounted for by 
ATP hydrolysis products, mainly adenosine acting on P1 re- 
ceptors, was discounted on the grounds that adenosine was 
far less effective than ATP and that ATPTS was as effective as 
ATP. We did not find any secretory effect induced by UTP 
while UTP and ATP are known to be equipotent to stimulate 
cells via P2-purinoceptor [26]. However, recent data demon- 
strate the occurrence of a pyrimidinergic receptor with high 
affinity to UTP [27,28] which is distinct from the purinergic 
receptor specific for ATP. It is therefore appealing to explain 
the lack of response to UTP by the absence of this pyrimidi- 
noceptor. This point will need more investigation, however. 
The lack of responsiveness to ATP by the CF cells is un- 
likely to derive from an absence of the receptor on the patho- 
logical cells or from an alteration in transduction mechanisms 
since normal and CF cells respond similarly to ATP by tran- 
sient intracellular calcium mobilization. McPherson et al. dem- 
onstrated an alteration of [3-adrenergic stimulation of mucin 
secretion by CF submandibular cells while [3-agonists were 
able to generate intracellular cyclic AMP in the same manner 
in normal and CF cells [29]. The authors postulated an altera- 
tion in a regulatory mechanism distal to the second messenger 
system. We here demonstrate hat in addition to an alteration 
in 13-adrenoceptor-induced s cretion, there is also an altera- 
tion in purinoceptor-induced s cretion which also appears dis- 
tal to the second messenger system. However, the alteration of 
adrenoceptor stimulation in CF cells concerns both chloride 
and mucin secretion. Since it has been shown that ATP in- 
duced chloride conductance in CF cells, the occurrence of no 
ATP-induced mucin secretion can have interesting therapeutic 
consequences. ATP is used as a therapeutic agent in the CF 
lung because of its action on fluid and electrolyte transport. 
However, no data were given about its possible action on 
mucin secretion. A stimulation of mucin secretion by ATP 
would be very deleterious in CF patients. Thus, if it is con- 
firmed, our observation on mucin-secreting cells of the CF 
airways would be of relevance for the use of ATP in the 
disease. 
One interesting finding of this study was that extracellular 
ATP was a more efficient secretagogue for mucin secretion in 
comparison to maximal stimulation of signalling pathways 
acting through cAMP (forskolin, VIP) or phospholipase C 
(carbachol) in the normal epithelial cell line CAPAN-1 and 
in the transfected CF epithelial cell line CFPAC-PLJ-CFTR6. 
No significant response by CFPAC-1 cells and by CFPAC- 
PLJ6 cells was observed with any secretagogue we used. Car- 
bachol and VIP acting via phosphoinositide/Ca 2+ nd cAMP 
respectively, known to be physiological secretagogues for C1 
secretion [30,31], were shown to also stimulate mucin secre- 
tion in the T84 human colonic adenocarcinoma cell line [11] 
and in the human intestinal goblet cell line HT29-Cl.16E [10]. 
Forskolin, which raised intracellular cAMP, stimulated C1- 
secretion by increasing the magnitude of CFTR-mediated 
C1 conductance in the apical membrane [32], by a PKA- 
dependent stimulus, was capable of stimulating mucin secre- 
tion in a Ca2+-independent manner [33]. In addition, the 
above mentioned results of McPherson and Dormer [29] 
who have shown a defect in [3-adrenergic stimulation of mucin 
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and serous protein secretion from submandibular salivary tis- 
sues from CF patients and those of Bradbury et al. [34] dem- 
onstrating the correction by transfection of wild type 
CFTR,  of the defect in cAMP-mediated endocytosis and exo- 
cytosis in CFPAC-1 cells also correlated closely with our find- 
ings. 
In summary, we showed in this study that ATP is a potent 
secretagogue for mucin secretion by epithelial pancreatic ells, 
via a P2-purinoceptor, and that CF cells did not respond to 
ATP by stimulation of mucin secretion. I f  this phenomenon 
also occurs in the bronchotracheal tree or in the gastrointes- 
tinal tract of CF patients it would have relevance in the use of 
ATP as therapeutic agent. 
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